Jun
2026
Shanghai New International Expo Center
Visit us
stand E3A28, Finished Dosage
Zone
Shanxi Zhendong Pharmaceutical Co., Ltd.
Exhibitor at CPHI & PMEC China 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2017
Event information
CPHI & PMEC China 2026
-
16 Jun 2026 - 18 Jun 2026
-
Shanghai New International Expo Center
-
Visit us at stand E3A28, Finished Dosage
Products Featured at CPHI & PMEC China 2026
-
Product Abiraterone acetate tablets
Abiraterone works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.
Abiraterone is used together with steroid medication (prednisone or methylprednisolone) to treat prostate cancer that has spread to o... -
Product Bicalutamide capsules
50mg daily: Combination with luteinizing hormone releasing hormone (LHRH) analogs or surgical orchiectomy for the treatment of advanced prostatic carcinoma.
150mg daily: For the treatment of patients with locally advanced prostate cancer without distant metastasis, who are unsuitable or unwillin... -
Product Enzalutamide Soft Capsules
Suitable for metastatic resistance to prostate cancer (CRPC). After the failure of androgen deprivation of therapy (ADT), Enzalutamide can delay the progress of the disease by inhibiting the inhibitors of therogen receptor signaling pathway and improve the quality of life of patients.

